Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples

Breast cancers are categorized into three subtypes based on protein expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2/ERBB2). Patients enroll onto experimental clinical trials based on ER, PR, and HER2 status and, as receptor status...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Timothy R., Xiao, Yuanyuan, Spoerke, Jill M., Fridlyand, Jane, Koeppen, Hartmut, Fuentes, Eloisa, Huw, Ling Y., Abbas, Ilma, Gower, Arjan, Schleifman, Erica B., Desai, Rupal, Fu, Ling, Sumiyoshi, Teiko, O’Shaughnessy, Joyce A., Hampton, Garret M., Lackner, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223539/
https://www.ncbi.nlm.nih.gov/pubmed/25338319
http://dx.doi.org/10.1007/s10549-014-3163-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223539/
https://www.ncbi.nlm.nih.gov/pubmed/25338319
http://dx.doi.org/10.1007/s10549-014-3163-8

Ejemplares similares